Literature DB >> 12916665

Histology of Barrett's esophagus and dysplasia.

Maha Guindi1, Robert H Riddell.   

Abstract

This article explores issues related to the diagnosis of Barrett's esophagus (BE) in endoscopic biopsies and dysplasia in Barrett's epithelium. The definitions of BE, including long- and short-segment BE, are reviewed, with an emphasis on the significance of intestinal metaplasia (IM). IM of the gastroesophageal junction and cardia is reviewed and problems in its distinction from short-segment BE are discussed. In addition, the article reviews the classification of dysplasia in Barrett's mucosa, with reference to problematic areas, such as sampling error and interobserver variability. Biomarkers and their role in the diagnosis of dysplasia and stratification of risk are summarized.

Entities:  

Mesh:

Year:  2003        PMID: 12916665     DOI: 10.1016/s1052-5157(03)00005-9

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  3 in total

1.  The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.

Authors:  K Koss; R F Harrison; J Gregory; S J Darnton; M R Anderson; J A Z Jankowski
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

Review 2.  Review on novel concepts of columnar lined esophagus.

Authors:  Johannes Lenglinger; Stephanie Fischer See; Lukas Beller; Enrico P Cosentini; Reza Asari; Fritz Wrba; Martin Riegler; Sebastian F Schoppmann
Journal:  Wien Klin Wochenschr       Date:  2013-09-06       Impact factor: 1.704

3.  Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  E A Griffiths; S A Pritchard; S M McGrath; H R Valentine; P M Price; I M Welch; C M L West
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.